Not All Drugs Get Approved the Same Way: Exceptions to FDA Rules

This video is the second in a series about drug approval in the U.S., focusing on exceptions to standard approval processes. It covers controversies around FDA's speed, exceptions like abbreviated applications, and pathways such as accelerated approval, Fast Track, and Breakthrough Therapy. The video also discusses expanded access for life-threatening conditions, setting the stage for the next episode on drug approval controversies.

What new insight or understanding did you gain from this video?